Literature DB >> 30820754

Concussion Pathophysiology and Injury Biomechanics.

Rafael Romeu-Mejia1,2, Christopher C Giza1,2,3, Joshua T Goldman4,5,6,7,8.   

Abstract

PURPOSE OF REVIEW: The concussion public health burden has increased alongside our knowledge of the pathophysiology of mild traumatic brain injury (mTBI). The purpose of this review is to summarize our current understanding of mTBI pathophysiology and biomechanics and how these underlying principles correlate with clinical manifestations of mTBI. RECENT
FINDINGS: Changes in post-mTBI glutamate and GABA concentrations seem to be region-specific and time-dependent. Genetic variability may predict recovery and symptom severity while gender differences appear to be associated with the neuroinflammatory response and neuroplasticity. Ongoing biomechanical research has shown a growing body of evidence in support of an "individual-specific threshold" for mTBI that varies based on individual intrinsic factors. The literature demonstrates a well-characterized timeframe for mTBI pathophysiologic changes in animal models while work in this area continues to grow in humans. Current human research shows that these underlying post-mTBI effects are multifactorial and may correlate with symptomatology and recovery. While wearable sensor technology has advanced biomechanical impact research, a definitive concussion threshold remains elusive.

Entities:  

Keywords:  Biomechanical impact; Concussion pathophysiology; Concussion threshold; Linear-rotational acceleration; Mild traumatic brain injury; Neurometabolic cascade

Year:  2019        PMID: 30820754      PMCID: PMC6542913          DOI: 10.1007/s12178-019-09536-8

Source DB:  PubMed          Journal:  Curr Rev Musculoskelet Med        ISSN: 1935-9748


  9 in total

1.  Neurotrauma Prevention Review: Improving Helmet Design and Implementation.

Authors:  Michael Goutnik; Joel Goeckeritz; Zackary Sabetta; Tala Curry; Matthew Willman; Jonathan Willman; Theresa Currier Thomas; Brandon Lucke-Wold
Journal:  Biomechanics (Basel)       Date:  2022-09-23

Review 2.  The More, the Better: High-Dose Omega-3 Fatty Acids Improve Behavioural and Molecular Outcomes in Preclinical Models in Mild Brain Injury.

Authors:  Craig S Patch; Elisa L Hill-Yardin; Michael Lewis; Lisa Ryan; Ed Daly; Alan J Pearce
Journal:  Curr Neurol Neurosci Rep       Date:  2021-07-06       Impact factor: 5.081

3.  Transient effects of multi-infusion ketamine augmentation on treatment-resistant depressive symptoms in patients with treatment-resistant bipolar depression - An open-label three-week pilot study.

Authors:  Chuanjun Zhuo; Feng Ji; Hongjun Tian; Lina Wang; Feng Jia; Deguo Jiang; Ce Chen; Chunhua Zhou; Xiaodong Lin; Jingjing Zhu
Journal:  Brain Behav       Date:  2020-07-03       Impact factor: 2.708

Review 4.  A window into eye movement dysfunction following mTBI: A scoping review of magnetic resonance imaging and eye tracking findings.

Authors:  Matthew A McDonald; Maryam Tayebi; Joshua P McGeown; Eryn E Kwon; Samantha J Holdsworth; Helen V Danesh-Meyer
Journal:  Brain Behav       Date:  2022-07-21       Impact factor: 3.405

Review 5.  Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair.

Authors:  Emily Leung; Lili-Naz Hazrati
Journal:  Brain Commun       Date:  2021-05-27

6.  Group characterization of impact-induced, in vivo human brain kinematics.

Authors:  Arnold D Gomez; Philip V Bayly; John A Butman; Dzung L Pham; Jerry L Prince; Andrew K Knutsen
Journal:  J R Soc Interface       Date:  2021-06-23       Impact factor: 4.293

Review 7.  Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury.

Authors:  Alison E Willing; Mahasweta Das; Mark Howell; Shyam S Mohapatra; Subhra Mohapatra
Journal:  CNS Neurosci Ther       Date:  2020-03-10       Impact factor: 5.243

Review 8.  Post-concussive Dizziness: A Review and Clinical Approach to the Patient.

Authors:  Gerard J Gianoli
Journal:  Front Neurol       Date:  2022-01-04       Impact factor: 4.003

9.  Cerebral blood flow is associated with matrix metalloproteinase levels during the early symptomatic phase of concussion.

Authors:  Nathan W Churchill; Alex P Di Battista; Shawn G Rhind; Doug Richards; Tom A Schweizer; Michael G Hutchison
Journal:  PLoS One       Date:  2021-11-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.